TVM Life Science Ventures VI GmbH & Co KG Insider Trading $TARA Protara Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TVM Life Science Ventures VI GmbH & Co KG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TVM Life Science Ventures VI GmbH & Co KG. TVM Life Science Ventures VI GmbH & Co KG is Director in Acer Therapeutics Inc. ($OPXA) and Director in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in PROTEON THERAPEUTICS INC ($PRTO).
TVM Life Science Ventures VI GmbH & Co KG in Protara Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of TVM Life Science Ventures VI GmbH & Co KG: 10% Owner
Holdings: 1,943,059 shares
Current Value: $3,788,965
Latest Transaction: Jun 26 2017
$TARA Market Capitalization: $31.94M
$TARA Previous Close: $1.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of TVM Life Science Ventures VI GmbH & Co KG in Protara Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACER, CNCE, TARA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26 2017 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | P | 0.99 | 128 | 127 | 500 | |
| Jun 26 2017 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | P | 0.99 | 372 | 370 | 500 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | J | 0.00 | 451,276 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | J | 0.00 | 1,316,683 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | X | 4.60 | 39,932 | 183,779 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | X | 4.60 | 116,511 | 536,219 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 1,277,663 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 3,727,823 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 799,043 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 2,331,391 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 835,121 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 2,436,618 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 717,260 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 2,092,735 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 1,531,518 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 4,468,482 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | X | 4.60 | 39,932 | 183,779 | 1,943,059 | 1.9 M to 1.9 M (+2.10 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | X | 4.60 | 116,511 | 536,219 | 1,903,127 | 1.8 M to 1.9 M (+6.52 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | C | 0.00 | 379,462 | 0 | 1,786,616 | 1.4 M to 1.8 M (+26.97 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | C | 0.00 | 1,107,154 | 0 | 1,407,154 | 300 K to 1.4 M (+369.05 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | P | 10.00 | 76,590 | 765,900 | 300,000 | 223.4 K to 300 K (+34.28 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | P | 10.00 | 223,410 | 2,234,100 | 223,410 | 0 to 223.4 K |
Page: 1